我院2013-2015年麻醉药品应用分析

发布时间：2019-03-06 16:38

【摘要】：目的:评价我院麻醉药品的应用现状及趋势,为麻醉药品的科学管理和合理使用提供参考。方法:对我院2013-2015年麻醉药品的销售金额、用药频度(DDDs)、日均费用(DDC)和排序比(B/A)等进行统计、分析。结果:我院麻醉药品销售金额逐年增加,且以注射剂为主。枸橼酸舒芬太尼注射液的销售金额和DDDs在2013-2015年均居首位,盐酸吗啡缓释片和枸椽酸芬太尼注射液的DDDs分列第2、3位。DDC排序列前3位的分别是盐酸羟考酮缓释片(40 mg)、注射用盐酸瑞芬太尼(2 mg)和枸橼酸舒芬太尼注射液。枸橼酸舒芬太尼注射液、盐酸吗啡片和盐酸羟考酮缓释片(10 mg)的B/A值接近1.0,其经济效益和社会效益同步性较好。结论:我院麻醉药品的销售金额逐年增加,麻醉药品的使用和管理基本符合相关标准和治疗规范,但在今后的工作中仍需加强管理。
[Abstract]:Objective: to evaluate the current situation and trend of the application of narcotic drugs in our hospital, and to provide reference for the scientific management and rational use of narcotic drugs. Methods: the sales amount of narcotic drugs in our hospital from 2013 to 2015, the daily average cost of (DDDs), and the ranking ratio (Ba A) of drug frequency from 2013 to 2015 were analyzed and analyzed. Results: the sales amount of narcotic drugs in our hospital increased year by year, and the injection was the main one. The sales amount and DDDs of sufentanil citrate were the highest in 2013-2015, and the DDDs of morphine hydrochloride sustained-release tablets and fentanyl citrate injection ranked 2nd and 3rd respectively. The top three were oxycodone hydrochloride sustained-release tablets (40 mg),). Remifentanil hydrochloride (2 mg) and sufentanil citrate were used for injection. The B / A ratio of sufentanil citrate injection, morphine hydrochloride tablets and oxycodone hydrochloride sustained-release tablets (10 mg) was close to 1.0, and its economic and social benefits were in good synchrony. Conclusion: the amount of sales of narcotic drugs in our hospital increases year by year. The use and management of narcotic drugs basically accord with the relevant standards and treatment norms, but it is still necessary to strengthen the management in the future work.
【作者单位】：重庆市急救医疗中心药剂科;
【分类号】：R95

【相似文献】